3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Promyelocytic, Acute
4
Leukemia
3
Neuroblastoma
2
Multiple Myeloma
2
Leukemia, Myeloid, Acute
2
Wilms Tumor
1
Testicular Neoplasms
1
Teratoma
1
Skin Neoplasms
1
Sarcoma
1
Retinoblastoma
1
Recurrence
1
Ovarian Neoplasms
1
Ovarian Germ Cell Cancer
1
Osteosarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Medulloblastoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Kidney Neoplasms
1
Hepatoblastoma
1
Endometrial Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Childhood Acute Promyelocytic Leukemia With PML-RARA
1
Central Nervous System Neoplasms
1
Carcinoma, Small Cell
1
Interventions
Temozolomide
53
Bevacizumab
45
Radiotherapy
28
Radiosurgery
21
Carboplatin
14
Erlotinib Hydrochloride
11
Radiation
10
pembrolizumab
9
Magnetic Resonance Spectroscopy
9
Etoposide
9
Vorinostat
8
Trastuzumab
8
Irinotecan
8
Sunitinib
7
Sorafenib
7
Radiotherapy, Intensity-Modulated
7
Lomustine
7
Lapatinib
7
Capecitabine
7
dabrafenib
6
Ipilimumab
6
Imatinib Mesylate
6
Cyclophosphamide
6
Sirolimus
5
Hydroxyurea
5
Everolimus
5
Bortezomib
5
temsirolimus
4
cabozantinib
4
binimetinib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Brain Neoplasms
×
Arsenic Trioxide
×
Clear all
No trials found.